English | Español

Technology/Innovation
+ Technology/Innovation
Press release submission | Nov 26, 2018

OBI PHARMA INC.: Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
+ Regulatory
Press release submission | Nov 26, 2018

ABBVIE: Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
+ Technology/Innovation
Press release submission | Nov 19, 2018

ALLEN TECHNOLOGIES: Hunt Regional Medical Center Improving Patient Experience with Allen’s Interactive Patient Engagement Solution
+ Technology/Innovation
Press release submission | Nov 19, 2018

AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS: Patients with shoulder arthritis have new options to avoid risks of total shoulder replacement
+ Community
Marian Johns | Nov 15, 2018

University of Pittsburgh cancer center among few to offer immunotherapy for non-Hodgkin lymphoma
+ Technology/Innovation
Press release submission | Nov 14, 2018

CCRM: Offers Breakthrough Clinical Trial of Non-Invasive Preimplantation Genetic Testing to Patients
+ Community
Press release submission | Nov 14, 2018

AMERICAN DIABETES ASSOCIATION: Issues Position Statement on Comprehensive Care of Pediatric Patients with Type 2 Diabetes
+ Technology/Innovation
Danielle Pacey | Nov 14, 2018

Study examines inhaled insulin for treating Type 1 diabetes

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation